Search research articles
Contact Us
Filters
Showing results (111-120 of 136) with videos related to
Page
of 14
Sort By:
Bioanalysis
|
May 12, 2018
UHPLC-MS/MS bioanalysis of human plasma coproporphyrins as potential biomarkers for organic anion-transporting polypeptide-mediated drug interactions
Hamza Kandoussi, Jianing Zeng, Kumar Shah, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 19, 2016
Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition
Yurong Lai, Sandhya Mandlekar, Hong Shen, et al.
Clinical Pharmacology and Therapeutics
|
May 28, 2020
Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications
Maciej J Zamek-Gliszczynski, Mitesh Patel, Xinning Yang, et al.
Clinical Pharmacology and Therapeutics
|
May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective
Kunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 23, 2017
Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys
Hong Shen, David M Nelson, Regina V Oliveira, et al.
Clinical Pharmacology and Therapeutics
|
October 23, 2018
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium
Xiaoyan Chu, Mingxiang Liao, Hong Shen, et al.
Clinical Pharmacology and Therapeutics
|
June 9, 2019
Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper
Bhagwat Prasad, Brahim Achour, Per Artursson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 6, 2015
Rosuvastatin Liver Partitioning in Cynomolgus Monkeys: Measurement In Vivo and Prediction Using In Vitro Monkey Hepatocyte Uptake
Bridget L Morse, Hong Cai, Jamus G MacGuire, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 27, 2015
Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation
Hong Shen, Tongtong Liu, Hao Jiang, et al.
Clinical and Translational Science
|
April 14, 2022
Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugs
Tatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 136) with videos related to
Sort By:
Page
of 14
Bioanalysis
|
May 12, 2018
UHPLC-MS/MS bioanalysis of human plasma coproporphyrins as potential biomarkers for organic anion-transporting polypeptide-mediated drug interactions
Hamza Kandoussi, Jianing Zeng, Kumar Shah, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 19, 2016
Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition
Yurong Lai, Sandhya Mandlekar, Hong Shen, et al.
Clinical Pharmacology and Therapeutics
|
May 28, 2020
Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications
Maciej J Zamek-Gliszczynski, Mitesh Patel, Xinning Yang, et al.
Clinical Pharmacology and Therapeutics
|
May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective
Kunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 23, 2017
Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys
Hong Shen, David M Nelson, Regina V Oliveira, et al.
Clinical Pharmacology and Therapeutics
|
October 23, 2018
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium
Xiaoyan Chu, Mingxiang Liao, Hong Shen, et al.
Clinical Pharmacology and Therapeutics
|
June 9, 2019
Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper
Bhagwat Prasad, Brahim Achour, Per Artursson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 6, 2015
Rosuvastatin Liver Partitioning in Cynomolgus Monkeys: Measurement In Vivo and Prediction Using In Vitro Monkey Hepatocyte Uptake
Bridget L Morse, Hong Cai, Jamus G MacGuire, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 27, 2015
Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation
Hong Shen, Tongtong Liu, Hao Jiang, et al.
Clinical and Translational Science
|
April 14, 2022
Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugs
Tatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, et al.
Page
of 14